In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

ViroPharma closes $62.5mm private placement of notes

Executive Summary

ViroPharma (targets physician specialists focused in gastroenterology and transplant medicine) grossed $62.5mm through the private placement of one-year senior secured bridge notes due 2005 along with warrants to purchase 5mm shares. The notes offering was made to selected qualified institutional investors under Regulation D.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement
    • Convertible Debt

Related Companies

Advertisement
UsernamePublicRestriction

Register